Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · IEX Real-Time Price · USD
67.90
+2.18 (3.32%)
At close: Apr 19, 2024, 4:00 PM
67.77
-0.13 (-0.19%)
After-hours: Apr 19, 2024, 6:09 PM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $3.22 billion as of April 19, 2024. Its market cap has increased by 13.64% in one year.
Market Cap
3.22B
Enterprise Value
3.02B
1-Year Change
13.64%
Ranking
Category
Stock Price
$67.90
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $3.22B, an increase of 1,976.64%. That is a compound annual growth rate of 43.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 19, 2024 | 3.22B | 3.32% |
| Apr 18, 2024 | 3.11B | -5.73% |
| Apr 17, 2024 | 3.30B | 1.31% |
| Apr 16, 2024 | 3.26B | 0.88% |
| Apr 15, 2024 | 3.23B | -1.36% |
| Apr 12, 2024 | 3.28B | -3.60% |
| Apr 11, 2024 | 3.40B | 1.07% |
| Apr 10, 2024 | 3.36B | -2.30% |
| Apr 9, 2024 | 3.44B | 0.73% |
| Apr 8, 2024 | 3.42B | -0.19% |
| Apr 5, 2024 | 3.42B | 0.11% |
| Apr 4, 2024 | 3.42B | -1.81% |
| Apr 3, 2024 | 3.48B | -1.42% |
| Apr 2, 2024 | 3.53B | -3.16% |
| Apr 1, 2024 | 3.65B | -3.52% |
| Mar 28, 2024 | 3.78B | 0.80% |
| Mar 27, 2024 | 3.75B | 3.19% |
| Mar 26, 2024 | 3.63B | -0.81% |
| Mar 25, 2024 | 3.66B | -4.10% |
| Mar 22, 2024 | 3.82B | -0.25% |
| Mar 21, 2024 | 3.83B | 2.55% |
| Mar 20, 2024 | 3.74B | 2.58% |
| Mar 19, 2024 | 3.64B | 5.97% |
| Mar 18, 2024 | 3.44B | -3.97% |
| Mar 15, 2024 | 3.58B | 8.32% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 3.37B |
| Oscar Health | 3.32B |
| Iovance Biotherapeutics | 3.25B |
| Fortrea Holdings | 3.23B |
| Bausch Health Companies | 3.18B |
| SpringWorks Therapeutics | 3.17B |
| Progyny | 3.14B |
| Amicus Therapeutics | 3.13B |